Locking Solutions for Hemodialysis Catheters; Heparin and Citrate—A Position Paper by ASDIN
Authors:
- John E. MoranJMJohn E. Moran
- Stephen R. AshSAStephen R. Ash
- the Clinical Practice CommitteeTCthe Clinical Practice Committee
- 1 September 2008
- journal article
- practice guideline
- Published by Wiley in Seminars in Dialysis
- Vol. 21 (5) , 490-492
Abstract
There is wide variation in the use of solutions to “lock” or fill tunneled central venous catheters for dialysis. Some centers use undiluted heparin concentrations ranging from 1000 to 10,000 U/ml and other centers place from 1000 to 10,000 U per lumen. Based on available evidence, it appears that heparin 1000 U/ml, or 4% sodium citrate are suitable choices for lock solution to maintain patency of tunneled central venous catheters for dialysis. Risks from systemic anticoagulation are lower with heparin 1000 U/ml and 4% sodium citrate, compared with higher concentrations of heparin (5000 and 10,000 U/ml). The need for use of tissue plasminogen activator for maintaining catheter patency is increased by using heparin lock at 1000 U/ml, vs. higher concentrations. Higher concentrations of heparin lock should be reserved for patients who have evidence of catheter occlusion or thrombosis when heparin is used at 1000 U/ml. Similar choices for lock solution are sensible for acute hemodialysis catheters. When heparin is used for catheter lock, the injected volume should not exceed the internal volume of the catheter.Keywords
This publication has 21 references indexed in Scilit:
- Citrate 4% versus Heparin and the Reduction of Thrombosis Study (CHARTS)Clinical Journal of the American Society of Nephrology, 2008
- Concentration of Heparin-Locking Solution and Risk of Central Venous Hemodialysis Catheter MalfunctionASAIO Journal, 2007
- Catheter lock heparin concentration: Effects on tissue plasminogen activator use in tunneled cuffed cathetersHemodialysis International, 2007
- Comparison of Low-Dose Gentamicin With Minocycline as Catheter Lock Solutions in the Prevention of Catheter-Related BacteremiaAmerican Journal of Kidney Diseases, 2006
- Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysisJournal of Clinical Laboratory Analysis, 2005
- Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Hemodialysis PatientsJournal of the American Society of Nephrology, 2005
- Heparin Stimulates Staphylococcus aureus Biofilm FormationInfection and Immunity, 2005
- Locking of tunneled hemodialysis catheters with gentamicin and heparinKidney International, 2004
- Radiological placement of the AshSplit haemodialysis catheter: a prospective analysis of outcome and complicationsNephrology Dialysis Transplantation, 2002
- Risk of heparin lock‐related bleeding when using indwelling venous catheter in haemodialysisNephrology Dialysis Transplantation, 2001